Humulin 70/30 Insulin

What Type of Humulin R Insulin Is? Humulin 70/30 Insulin Is A Type Of Insulin That Is Obtained and contains human regular insulin and isophane insulin. Insulin NPH is considered as intermediate-acting insulin but regular insulin is short-acting insulin used by SubQ injection. Furthermore, compared to insulin NPH the combination product has a shorter onset of action and almost a similar duration of action.

Humulin 70/30 N & R Insulin Injection Pen Uses Dosage Side Effects
Insulin Humulin 70/30
More Medications: Actrapid HM Insulin Uses, Dosage Administration And Side Effects

Insulin Humulin Indications And Usage

Humulin 70/30 R Regular Insulin is a fixed ratio premix recombinant human insulin formulation indicated to improve glycemic control in adult patients with diabetes mellitus.

Humulin 70/30 Insulin Dosage And Administration

Important Administration Instruction For Humulin Insulin Pen

Inspect Humulin 70/30 Insulin visually before use. It should not contain particulate matter and should appear uniformly cloudy after mixing. Do not use Humulin 70/30 if particulate matter is seen. Do not mix Humulin 70/30 with any other insulins or diluents.

Route Of Administration For Humulin R and Humulin N

HUMULIN 70/30 should only administration subcutaneously. Administer in the subcutaneous tissue of the abdominal wall, thigh, upper arm, or buttocks. To reduce the risk of lipodystrophy, rotate the injections site within the same region from one injection to the next. Do not administration HUMULIN Insulin intravenously or intramuscularly and do not use HUMULIN Insulin Pen in an insulin injection infusion pump.

Humulin Dosage Informations

Individualize and adjust the Dosage of HUMULIN Insulin 70/30 based on the individual’s metabolic needs, blood glucose monitoring result, and glycemic control goal. Dosage adjustments needed with a change in physical activity. Change in meal patterns changes in renal or hepatic function or during acute illness. The proportion of rapid-acting and long-acting insulin fixed in premixed insulin such as HUMULIN Insulin 70/30. Independent adjustment of the basal or prandial dose is not possible when using premixed insulin.

Physiological factors, disease states, and concomitant medical products may impact the onset and duration of action of all insulin. HUMULIN Dose requirements may change with changes in the level of physical activity, meal patterns, during major illness, Or with some co-administered medical products.

Timing Of Subcutaneous Administrations

Humulin Dosage give subcutaneously approximately 30-45 minutes before a meal .

Dosage Forms And Strengths

HUMULIN injections Suspension Dosage; 100 units per ml (U-100) available as:

  • 3 ml vials
  • 10 Ml vials
  • 3 ml pre-filled pens
  • 3 ML HUMULIN Insulin 70/30 N Kwikpen (prefilled )

Humulin Contraindications

HUMULIN 70/30 Insulin contraindicated in:

  • During episodes of hypoglycemia
  • In patients who have had hypersensitivity reactions to HUMULIN 70/30 or any of its excipients.

Humulin Insulin Side Effects

The following Humulin Insulin Side Effects are discussed:

  • Hypoglycemia
  • Hypoglycemia

The following additional Humulin Insulin Side Effects identified during post-approval use. Because these reactions are reported voluntarily from a population of uncertain size. It is not always possible to reliably estimate their frequency or to establish a casual relationship exposure.

Allergic Reaction

Some patients taking HUMULIN 70/30 have experienced

  • Erythema
  • Local Edema
  • Pruritus

at the site of injection. These conditions usually self-limiting, severe cases of generalized allergy reported.

Peripheral Edema

Meanwhile, Some patients taking HUMULIN 70/30 Insulin have experienced sodium retention and edema. Particularly if previously poor metabolic control improved by intensified insulin therapy.

Lipodystrophy

In addition, the Administration of insulin subcutaneously, including HUMULIN, has resulted in

  • Lipoatrophy
  • Depression in the skin
  • Lipohypertrophy Enlargement
  • Thickening of tissue
Weight Gain

Firslty, Weight gain has occurred with some insulin therapies including HUMULIN 70/30. And has attributed to the anabolic effects of insulin and the decrease in glycosuria.

Immunogenicity

Similarly, the Development of antibodies that react with human insulin have observed with all insulin, including HUMULIN 70/30.

Humulin Interactions

Products That May Increase The Risk Of Hypoglycemia

Most importantly, The risk of hypoglycemia associated with HUMULIN 70/30 use may be increased when co-administration with

  • Antidiabetic Agents
  • Salicylates
  • Sulfonamide Antibiotic
  • Monoamine Oxidase Inhibitors
  • Fluoxetine
  • Disopyramide
  • Fibrates
  • Propoxyphene
  • Pentoxifylline
  • ACE Inhibitors
  • Angiotensin ll Receptor Blocking Agents
  • Somatostain Analogs Octrotide

Meanwhile, the Humulin Dose adjustment and increased frequency of glucose monitoring required. But when HUMULIN Insulin co-administration with these Medical products.

Products That May Decrease The Blood Glucose Lowering Effect Of HUMULIN 70/30

However, The glucose-lowering effect of HUMULIN 70/ 30 may decreased when co-administration with

  • Corticosteroids
  • Isoniazid
  • Niacin
  • Estrogens
  • Oral Contraceptives
  • Phenothiazines
  • Danazol
  • Diuretics
  • Sympathomimetic Agents
  • Epinephrine
  • Albuterol
  • Terbutailne
  • Somatropin
  • Atypical Antipsychotics
  • Glucagon
  • Protease inhibitors
  • Thyroid Hormones

Humulin R Insulin Dosage adjustment and increased frequency of glucose monitoring required when co-administration with these medical products.

Medical Products That May Blunt Signs And Symptoms Of Hypoglycemia

Firstly, the signs and symptoms of hypoglycemia may be blunted when

  • Beta Blockers
  • Clonidine
  • Gunethidine
  • Reserpine

Meanwhile, these are co-administration with Humulin Insulin.

Insulin Uses In During Pregnancy

Pregnancy Category B

Risk Summary

However, All pregnancies have a background risk of birth defects, loss, or another adverse outcome regardless of medical product exposure. So, This background risk increased in pregnancies complicated by hyperglycemia and decreased with good metabolic control. Therefore, It is essential for patients with diabetes or a history of gestational diabetes to maintain good metabolic control before conception and throughout pregnancy. Meanwhile, patients with diabetes or gestational, diabetes. Consequently, insulin requirements may decrease during the first trimester. Generally increase during the second and third trimesters, and rapidly decline after delivery. Careful monitoring of glucose control essential in these patients. Therefore, female patients advised telling their physicians if they use Humulin insulin during pregnancy.

Human Data

Meanwhile, there are no adequate and well-controlled studies of HUMULIN 70/ 30 Insulin During Pregnancy in pregnant women. So, the Evidence suggests that good glycemic control in patients with diabetes during pregnancy provided significant maternal and fetal benefits.

Insulin For Child

Similarly, Safety and effectiveness of Humulin 70/ 30 Insulin For Child patients less than 18 years of age have not established.

 

Geriatric use

Firstly, The effect of age on the pharmacokinetics and pharmacodynamics of HUMULIN 70/ 30 not studied. On the other hand, Patients with advanced using insulin including HUMULIN70/30 may at increased risk of hypoglycemia due to co-morbid disease and polypharmacy.

Renal Impairment

Firstly, The effect of renal impairment on the pharmacokinetics and pharmacodynamics of HUMULIN 70 / 30 has not been studied. Meanwhile, Patients with renal impairment are at increased risk of hypoglycemia are may require more frequent HUMULIN 70/ 30 dose adjustment and more frequent blood glucose monitoring.

Hepatic impairment

The effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of HUMULIN 70/ 30 patients with hepatic impairment are at increase risk of hypoglycemia. And may require more frequent HUMULIN 70/ 30 dose adjustment and more frequent blood glucose monitoring.

Insulin Overdose And Treatment

Insulin overdose administration may cause hypoglycemia and hypokalemia. Meanwhile, Mild episodes of hypoglycemia treat with oral glucose. On the other hand, Adjustment in Insulin dosage, meal patterns or physical activity level may be needed. Moreover, severe episodes with coma epizure, or neurologic impairment may be treated with intramuscular, subcutaneous glucagon or concentration intravenous glucose. In addition, Sustained carbohydrate intake and observation may necessary because hypoglycemia may recur after apparent clinical recovery. Lastly, the Hypokalemia must be corrected appropriately.

Humulin 70/30 Insulin Storage And Handling

Firstly, protect Humulin Insulin from sunlight and do not freeze. Most importantly, store 2C to 8C temperature, do not use if frozen. Meanwhile, each prefilled Humulin Insulin pen and Humulin Insulin KwikPen is only for use by a single patient. However, Vials must be discarded after 31 days.

More Medical Information: Levosulpiride 25 MG Tablet

Lantus Vs Humulin N Insulin Comparison You Must Read This

Leave a Reply